🔎 Trials Near Me

ホーム › 動脈硬化 › ユタ

ユタにおける動脈硬化の臨床試験

ユタ内の拠点で、動脈硬化に関する8件の研究が参加者を募集しています。

ユタ内の都市

公式研究テキスト(英語)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Ogden Clinic - Canyon View, Ogden
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Intermountain Medical Center, Murray
  • Ogden Clinic - Canyon View, Ogden
  • Advanced Research Institute, Ogden
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Boeson Research, Provo
  • Velocity Clinical Research - Salt Lake City, West Jordan
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

  • Intermountain Medical Center, Murray
被験者募集中第3相
45歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07613294

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Bountiful
  • Research Site, Ogden
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

  • Intermountain Medical Center, Murray
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/07更新 · NCT06813911

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
被験者募集中第4相
18歳以上 · 全性別 · 2025/12/17更新 · NCT02915198

A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

  • Intermountain Healthcare Hospitals and Clinics, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2025/05/06更新 · NCT06571162

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。